Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term hepatitis B antibody persistence and challenge response study in 11-12-year-old children previously vaccinated in infancy
2009-016911-39Phase 4Completed
- Sponsor
- GSK
- Start
- Apr 2010
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of Hepatitis B vaccine in hepatitis B (HBV) (2 arms), sponsored by GSK. Primary endpoint: Anti-HBs antibody response one month after challenge dose. Started Apr 2010; status: completed.
02
Drugs
Hepatitis B vaccine
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on 2009-016911-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-016911-39.